Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Performance of a Pelvic Floor Mesh Implant (LatGYNious)

NCT: NCT07066761 · RECRUITING

NCT IDNCT07066761
StatusRECRUITING
Start Date2025-11-01
Completion2028-04
SponsorA.M.I. Agency for Medical Innovations GmbH (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of the clinical investigation is to verify that the investigational device (LatGYNious) is appropriate to significantly improve the pelvic organ prolapse in patients.

Frequently Asked Questions

What is Safety and Performance of a Pelvic Floor Mesh Implant (LatGYNious)?

Safety and Performance of a Pelvic Floor Mesh Implant (LatGYNious) is a clinical trial registered under NCT07066761. Current status: RECRUITING.

What is the status of NCT07066761?

The current status of NCT07066761 (Safety and Performance of a Pelvic Floor Mesh Implant (LatGYNious)) is: RECRUITING.

When did Safety and Performance of a Pelvic Floor Mesh Implant (LatGYNious) start?

Safety and Performance of a Pelvic Floor Mesh Implant (LatGYNious) started on 2025-11-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.